Related references
Note: Only part of the references are listed.Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations
Dwight A. Winter et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
Proactively Optimized Infliximab Monotherapy Is as Effective as Combination Therapy in IBD
Sara Lega et al.
INFLAMMATORY BOWEL DISEASES (2019)
Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation
Sophie E. Berends et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children With Inflammatory Bowel Disease
Debora Curci et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Nicholas A. Kennedy et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease
Travis Piester et al.
INFLAMMATORY BOWEL DISEASES (2018)
Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel Disease
Konstantinos Papamichael et al.
JOURNAL OF CROHNS & COLITIS (2018)
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition
Dan Turner et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease
Karen van Hoeve et al.
JOURNAL OF CROHNS & COLITIS (2018)
Biological Therapy in Pediatric Inflammatory Bowel Disease A Systematic Review
Domenico Corica et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)
A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs
Andrew R. Reinink
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseases
Eva L. Kneepkens et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Serum Infliximab, Antidrug Antibodies, and Tumor Necrosis Factor Predict Sustained Response in Pediatric Crohn's Disease
Ronen Stein et al.
INFLAMMATORY BOWEL DISEASES (2016)
Sample Size for Assessing Agreement between Two Methods of Measurement by Bland-Altman Method
Meng-Jie Lu et al.
INTERNATIONAL JOURNAL OF BIOSTATISTICS (2016)
Sample Size for Assessing Agreement between Two Methods of Measurement by Bland-Altman Method
Meng-Jie Lu et al.
INTERNATIONAL JOURNAL OF BIOSTATISTICS (2016)
Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children
Lisa C. Martial et al.
PLoS One (2016)
A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated with blood hematocrit
Neil Spooner et al.
BIOANALYSIS (2015)
Understanding Bland Altman analysis
Davide Giavarina
BIOCHEMIA MEDICA (2015)
Early Infliximab Trough Levels Are Associated with Persistent Remission in Pediatric Patients with Inflammatory Bowel Disease
Namita Singh et al.
INFLAMMATORY BOWEL DISEASES (2014)
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
F. M. Ruemmele et al.
JOURNAL OF CROHNS & COLITIS (2014)
Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
N. Vande Casteele et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Share Paper
